Who invested in Intellia Therapeutics?
Intellia Therapeutics's investors include Novartis, Atlas Venture, OrbiMed, Foresite Capital and Fidelity, and 5 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$485Mraised across 3 rounds since 2014, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $70M sold, first sale Aug 2015
From Intellia Therapeutics's own website and the SEC filings it signed: 8 on the team.
On the board, as filediCarl GordonJean-Francois FormelaRachel Haurwitz
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Intellia Therapeutics's investors include Novartis, Atlas Venture, OrbiMed, Foresite Capital and Fidelity, and 5 more on record.
Intellia Therapeutics has raised $485M across 3 rounds since 2014.
Intellia Therapeutics's most recent round was a Debt of $400M in Sept 2026.
Its most recent round, $400M in Sept 2026, is also its largest on record.
Intellia Therapeutics's first round on record, in Nov 2014, was backed by Atlas Venture, Novartis and Caribou Biosciences.
Intellia Therapeutics's latest named round is a Debt, in Sept 2026.
Intellia Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.